BioCor, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BioCor, LLC - overview
Established
1998
Location
-, PA, US
Primary Industry
Software
About
BioCor, LLC focuses on delivering innovative biotechnology solutions aimed at addressing health and environmental challenges through research and development services and products. BioCor, LLC is engaged in biotechnology, emphasizing research and development services. Founded in 1998 in the US, it underwent a strategic acquisition by United Biosource Corporation in November 2006. The company was formed through a merger, further enhancing its capabilities in the biotech sector.
Biocor. com specializes in innovative solutions within the biotechnology sector, focusing on research and development services and products designed to address various health and environmental challenges. Their core product offerings include biological assays and diagnostic tools that facilitate precise measurements in clinical and laboratory settings, aimed at healthcare providers, research institutions, and pharmaceutical companies. Biocor’s products are marketed to clients in North America, Europe, and select markets in Asia, supporting scientific inquiries and decision-making processes.
Biocor generates revenue through a structured model that includes direct sales and partnerships with healthcare and research organizations. The company offers tiered pricing plans for its flagship products, catering to both large institutions and smaller laboratories. Regular transactions typically involve clients procuring diagnostic tools and biological assays on a subscription basis, ensuring access to the latest innovations. Partnerships with research institutions contribute significantly to their revenue model, enabling collaborative projects that enhance product development and application.
Looking ahead, BioCor is actively designing new products for launch in the coming years, with a focus on expanding its market presence in Europe and Asia by 2025. The company plans to utilize the resources from its acquisition deal in 2006 to support these initiatives, reinforcing its commitment to advancing health outcomes through innovative biotechnology solutions.
Current Investors
United BioSource Corporation
Primary Industry
Software
Sub Industries
Healthcare, Analytics & Performance Software, Medical Software
Website
www.biocor.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
BioCor, LLC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | BioCor, LLC | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.